Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorPrice, Anna
dc.contributor.authorFord, Tamsin
dc.contributor.authorJanssens, Astrid
dc.contributor.authorWilliams, Andrew James
dc.contributor.authorNewlove-Delgado, Tamsin
dc.date.accessioned2020-01-20T11:30:12Z
dc.date.available2020-01-20T11:30:12Z
dc.date.issued2020-01
dc.identifier.citationPrice , A , Ford , T , Janssens , A , Williams , A J & Newlove-Delgado , T 2020 , ' Regional analysis of UK primary care prescribing and adult service referrals for young people with attention-deficit hyperactivity disorder ' , BJPsych Open , vol. 6 , no. 1 , e7 . https://doi.org/10.1192/bjo.2019.94en
dc.identifier.issn2056-4724
dc.identifier.otherPURE: 265792539
dc.identifier.otherPURE UUID: f806268d-dceb-43cf-8afa-0b56b4dabf04
dc.identifier.otherORCID: /0000-0002-2175-8836/work/67526159
dc.identifier.otherScopus: 85087132763
dc.identifier.urihttp://hdl.handle.net/10023/19313
dc.description.abstractBackground Approximately 20% of children with attention-deficit hyperactivity disorder (ADHD) experience clinical levels of impairment into adulthood. In the UK, there is a sharp reduction in ADHD drug prescribing over the period of transition from child to adult services, which is higher than expected given estimates of ADHD persistence, and may be linked to difficulties in accessing adult services. Little is currently known about geographical variations in prescribing and how this may relate to service access. Aims To analyse geographic variations in primary care prescribing of ADHD medications over the transition period (age 16–19 years) and adult mental health service (AMHS) referrals, and illustrate their relationship with UK adult ADHD service locations. Method Using a Clinical Practice Research Datalink cohort of people with an ADHD diagnosis aged 10–20 in 2005 (study period 2005–2013; n = 9390, 99% diagnosed <18 years), regional data on ADHD prescribing over the transition period and AMHS referrals, were mapped against adult ADHD services identified in a linked mapping study.ResultsDifferences were found by region in the mean age at cessation of ADHD prescribing, range 15.8–17.4 years (P<0.001), as well as in referral rates to AMHSs, range 4–21% (P<0.001). There was no obvious relationship between service provision and prescribing variation. Conclusions Clear regional differences were found in primary care prescribing over the transition period and in referrals to AMHSs. Taken together with service mapping, this suggests inequitable provision and is important information for those who commission and deliver services for adults with ADHD.
dc.format.extent6
dc.language.isoeng
dc.relation.ispartofBJPsych Openen
dc.rightsCopyright © The Authors 2020. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectCPRDen
dc.subjectADHDen
dc.subjectTransitionen
dc.subjectPrescribingen
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subjectRJ Pediatricsen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subjectE-DASen
dc.subject.lccRC0321en
dc.subject.lccRJen
dc.subject.lccRMen
dc.titleRegional analysis of UK primary care prescribing and adult service referrals for young people with attention-deficit hyperactivity disorderen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews.School of Medicineen
dc.identifier.doihttps://doi.org/10.1192/bjo.2019.94
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record